tirzepatide diabetes trial Shows Superior Weight Loss Over Semaglutide in Phase 3 A 3-year study of tirzepatide

Company Categorization 8.3

Our functional testing goes deeper, analyzing how your white blood cells metabolize vitamins, minerals, and other essential compounds

- Reduce the accumulation of lactic acid in the muscles, preventing muscle aches

Tesamorelin: specifically reduces visceral (abdominal) fat

Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management (meta-analysis of SURPASS)

Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: a post hoc analysis of the SURPASS-1 to -5 studies